Northern Trust
ORGO icon

Northern Trust’s Organogenesis Holdings ORGO Stock Holding History

Northern Trust’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Buy
554,428
+20,126
+4% +$69.7K ﹤0.01% 3200
2025
Q4 		$2.77M Sell
534,302
-59,805
-10% -$290K ﹤0.01% 2802
2025
Q3 		$2.51M Sell
594,107
-194,066
-25% -$902K ﹤0.01% 2910
2025
Q2 		$2.88M Buy
788,173
+194,780
+33% +$726K ﹤0.01% 2790
2025
Q1 		$2.56M Sell
593,393
-22,696
-4% -$91.6K ﹤0.01% 2790
2024
Q4 		$1.97M Buy
616,089
+17,196
+3% +$57.7K ﹤0.01% 3035
2024
Q3 		$1.71M Buy
598,893
+9,898
+2% +$27.8K ﹤0.01% 3094
2024
Q2 		$1.65M Sell
588,995
-27,594
-4% -$74.1K ﹤0.01% 3008
2024
Q1 		$1.75M Sell
616,589
-9,318
-1% -$31.7K ﹤0.01% 3037
2023
Q4 		$2.56M Buy
625,907
+3,271
+0.5% +$9.16K ﹤0.01% 2863
2023
Q3 		$1.98M Buy
622,636
+21,526
+4% +$68.4K ﹤0.01% 2945
2023
Q2 		$2M Sell
601,110
-96,192
-14% -$284K ﹤0.01% 3005
2023
Q1 		$1.49M Sell
697,302
-43,261
-6% -$107K ﹤0.01% 3074
2022
Q4 		$1.99M Buy
740,563
+53,182
+8% +$155K ﹤0.01% 2996
2022
Q3 		$2.23M Buy
687,381
+13,259
+2% +$59.9K ﹤0.01% 2964
2022
Q2 		$3.29M Buy
674,122
+766
+0.1% +$4.71K ﹤0.01% 2779
2022
Q1 		$5.13M Buy
673,356
+201,487
+43% +$1.56M ﹤0.01% 2573
2021
Q4 		$4.36M Buy
471,869
+2,621
+0.6% +$27.8K ﹤0.01% 2772
2021
Q3 		$6.68M Sell
469,248
-13,288
-3% -$206K ﹤0.01% 2555
2021
Q2 		$8.02M Buy
482,536
+151,586
+46% +$2.83M ﹤0.01% 2525
2021
Q1 		$6.03M Sell
330,950
-1,646
-0.5% -$22.3K ﹤0.01% 2636
2020
Q4 		$2.5M Buy
332,596
+63,304
+24% +$301K ﹤0.01% 3082
2020
Q3 		$1.03M Sell
269,292
-9,852
-4% -$38.9K ﹤0.01% 3381
2020
Q2 		$1.07M Buy
279,144
+73,533
+36% +$265K ﹤0.01% 3327
2020
Q1 		$664K Buy
205,611
+52,249
+34% +$224K ﹤0.01% 3369
2019
Q4 		$737K Buy
153,362
+37,238
+32% +$236K ﹤0.01% 3481
2019
Q3 		$763K Buy
116,124
+75,058
+183% +$418K ﹤0.01% 3462
2019
Q2 		$312K Buy
41,066
+23,540
+134% +$173K ﹤0.01% 3688
2019
Q1 		$131K Buy
+17,526
New +$350K ﹤0.01% 3867

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust's ORGO Position: Q1 2026 in Review

Northern Trust increased its Organogenesis Holdings (ORGO) stake by 3.8% in Q1 2026, buying an estimated $69.7K and bringing the position to 554,428 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Northern Trust first reported a position in ORGO in Q1 2019 and has held it in 29 quarters since. The position peaked at $8.02M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Northern Trust held 554,428 shares of Organogenesis Holdings worth $1.31M as of Q1 2026.
  • Northern Trust bought 20,126 Organogenesis Holdings shares in Q1 2026, an estimated $69.7K.
  • Organogenesis Holdings made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3200 holding.
  • Northern Trust first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 29 quarters since.
  • Northern Trust's Organogenesis Holdings position peaked at $8.02M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.